Negative Regulator of Interferon Response (NRIR) and Interferon Signaling Pathway

Target Name: NRIR

NCBI ID: G104326052

NRIR

Negative Regulator of Interferon Response (NRIR) and Interferon Signaling Pathway

Interferon is a protein that plays a crucial role in the immune response against viruses and other pathogens. When interferon is produced, it activates a signaling pathway that regulates the fight against infections. However, interferon also has the potential to cause harm if it is produced at high levels or for an extended period. This protein is negatively regulated by a protein called Negative Regulator of Interferon Response (NRIR).NRIR is a non-protein coding RNA molecule that plays a critical role in regulating the activity of interferon.

NRIR is a small non-coding RNA molecule that is expressed in a variety of tissues and cells in the body. It is primarily located in the cytoplasm and is involved in the negative regulation of interferon.NRIR interacts with the protein called Stat3, which is a key regulator of interferon.

NRIR plays a crucial role in the regulation of interferon by binding to Stat3 and preventing it from activating the interferon signaling pathway.NRIR does this by modulating the activity of a protein called IRAK4, which is located in the nucleus.IRAK4 is a negative regulator of interferon that helps to keep interferon levels under control.

NRIR has been shown to play a critical role in the regulation of various cellular processes in the body, including cell growth, apoptosis, and inflammation. It has also been shown to be involved in the development and progression of various diseases, including cancer.

NRIR is a potential drug target and biomarker for a variety of diseases. For example, NRIR has been shown to be involved in the regulation of cancer cell growth and has been used as a potential therapeutic target in cancer treatment. Additionally, NRIR has been shown to be involved in the regulation of autoimmune diseases, including rheumatoid arthritis and lupus.

NRIR is also a potential biomarker for certain diseases, such as cancer. The levels of NRIR have been shown to be elevated in various types of cancer, which could make it a useful indicator of disease status in these conditions.

Conclusion

In conclusion, Negative Regulator of Interferon Response (NRIR) is a non-protein coding RNA molecule that plays a critical role in the regulation of interferon and the immune response. It is involved in the negative regulation of interferon by binding to the protein Stat3 and preventing it from activating the interferon signaling pathway.NRIR has been shown to play a crucial role in the regulation of various cellular processes in the body and is a potential drug target and biomarker for a variety of diseases. Further research is needed to fully understand the role of NRIR in the immune response and the development of disease.

Protein Name: Negative Regulator Of Interferon Response

The "NRIR Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about NRIR comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets